Zomedica Corp. (ZOMDF)
0.084
+0.01
(+6.50%)
USD |
OTCM |
Oct 05, 16:00
Zomedica Cash from Investing (Quarterly) : 0.3581M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3581M |
| March 31, 2026 | 5.622M |
| December 31, 2025 | 2.227M |
| September 30, 2025 | 4.073M |
| June 30, 2025 | 4.910M |
| March 31, 2025 | 8.406M |
| December 31, 2024 | 1.594M |
| September 30, 2024 | 6.545M |
| June 30, 2024 | 3.706M |
| March 31, 2024 | 5.625M |
| December 31, 2023 | -3.866M |
| September 30, 2023 | -3.130M |
| June 30, 2023 | 23.35M |
| March 31, 2023 | -14.79M |
| December 31, 2022 | -11.44M |
| September 30, 2022 | -136.40M |
| June 30, 2022 | -1.430M |
| March 31, 2022 | -0.206M |
| December 31, 2021 | -71.19M |
| September 30, 2021 | -0.1973M |
| June 30, 2021 | -0.1254M |
| March 31, 2021 | -0.018M |
| December 31, 2020 | 0.0147M |
| September 30, 2020 | 0.0277M |
| June 30, 2020 | -0.0147M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.008M |
| December 31, 2019 | -0.0285M |
| September 30, 2019 | -0.5876M |
| June 30, 2019 | -0.0052M |
| March 31, 2019 | -0.0691M |
| December 31, 2018 | -0.0115M |
| September 30, 2018 | -0.4597M |
| June 30, 2018 | -0.1231M |
| March 31, 2018 | -0.0132M |
| December 31, 2017 | |
| September 30, 2017 | -0.0134M |
| June 30, 2017 | -0.0011M |
| March 31, 2017 | -0.1574M |
| December 31, 2016 | -0.0089M |
| September 30, 2016 | -0.1288M |
| June 30, 2016 | -0.0215M |
| March 31, 2016 | -0.0803M |
| February 29, 2016 | |
| November 30, 2015 | |
| August 31, 2015 | |
| May 31, 2015 | |
| February 28, 2015 | 0.00 |
| November 30, 2014 | 0.00 |
| August 31, 2014 | 0.00 |
| May 31, 2014 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biomerica, Inc. | 0.018M |
| Univec, Inc. | 0.00 |
| Lantheus Holdings, Inc. | -2.023M |
| IDEXX Laboratories, Inc. | -25.50M |
| Neogen Corp. | -4.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.515M |
| Free Cash Flow | -14.80M |
| Free Cash Flow Per Share (Quarterly) | -0.0034 |
| Free Cash Flow to Equity (Quarterly) | -3.144M |
| Free Cash Flow to Firm (Quarterly) | -3.324M |
| Free Cash Flow Yield | -17.98% |